LAMEDITECH Co., Ltd.
Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system; and … Read more
LAMEDITECH Co., Ltd. (462510) - Total Liabilities
Latest total liabilities as of September 2025: ₩8.28 Billion KRW
Based on the latest financial reports, LAMEDITECH Co., Ltd. (462510) has total liabilities worth ₩8.28 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
LAMEDITECH Co., Ltd. - Total Liabilities Trend (2022–2024)
This chart illustrates how LAMEDITECH Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
LAMEDITECH Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of LAMEDITECH Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
01 Communique Laboratory Inc
OTCQB:OONEF
|
USA | $457.68K |
|
International Isotopes Inc
OTCQB:INIS
|
USA | $13.75 Million |
|
Digital Multimedia Technology Co.Ltd
KQ:134580
|
Korea | ₩27.79 Billion |
|
Logindo Samudramakmur Tbk
JK:LEAD
|
Indonesia | Rp1.01 Trillion |
|
Aimflex Bhd
KLSE:0209
|
Malaysia | RM18.32 Million |
|
TH International Limited
NASDAQ:THCH
|
USA | $2.32 Billion |
|
Ordell Minerals Ltd
AU:ORD
|
Australia | AU$834.66K |
Liability Composition Analysis (2022–2024)
This chart breaks down LAMEDITECH Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LAMEDITECH Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LAMEDITECH Co., Ltd. (2022–2024)
The table below shows the annual total liabilities of LAMEDITECH Co., Ltd. from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩3.19 Billion | +17.07% |
| 2023-12-31 | ₩2.73 Billion | -86.10% |
| 2022-12-31 | ₩19.61 Billion | -- |